Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc reported a quarterly adjusted loss of 8 cents per share for the quarter ended June 30, an improvement from a loss of 23 cents per share a year ago. Revenue increased by 19.2% to $1.16 million, slightly above analyst expectations. The company incurred a total loss of $7.89 million this quarter. Despite a 13.3% drop in shares this quarter, they have gained 21.8% year-to-date. Analysts maintain a "buy" rating, with a median 12-month price target of $3.00, indicating a potential upside of 66.8% from the last closing price of $1.00.
- Lucid Diagnostics Inc (LUCD.OQ) reported a quarterly adjusted loss of 8 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of six analysts for the quarter was for a loss of 12 cents per share. Wall Street expected results to range from -15 cents to -10 cents per share.
- Revenue rose 19.2% to $1.16 million from a year ago; analysts expected $1.14 million.
- Lucid Diagnostics Inc’s reported EPS for the quarter was a loss of 8 cents.
- The company reported a quarterly loss of $7.89 million.
- Lucid Diagnostics Inc shares had fallen by 13.3% this quarter and gained 21.8% so far this year. FORECAST CHANGES
- The mean earnings estimate of analysts had risen by about 3.2% in the last three months.
- In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS
- The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 6 “strong buy” or “buy,” no “hold” and no “sell” or “strong sell.” The average consensus recommendation for the medical equipment, supplies & distribution peer group is also “buy”
- Wall Street’s median 12-month price target for Lucid Diagnostics Inc is $3.00, about 66.8% above its last closing price of $1.00 This summary was machine generated from LSEG data August 13 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2025 -0.12 -0.08 Beat
Mar. 31 2025 -0.16 -0.52 Missed
Dec. 31 2024 -0.19 -0.18 Beat
Sep. 30 2024 -0.22 -0.25 Missed
